BlackRock Investment Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

BlackRock Investment Management’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$986K	Buy	56,235 +322	+0.6%	+$6.17K	﹤0.01%	2707
2016 Q3	$1.33M	Buy	55,913 +3,189	+6%	+$60.1K	﹤0.01%	2475
2016 Q2	$844K	Buy	52,724 +3,804	+8%	+$68.2K	﹤0.01%	2748
2016 Q1	$1.02M	Buy	48,920 +1,170	+2%	+$20.9K	﹤0.01%	2476
2015 Q4	$1.29M	Buy	47,750 +281	+0.6%	+$7.66K	﹤0.01%	2411
2015 Q3	$1.32M	Buy	47,469 +6,983	+17%	+$220K	﹤0.01%	2391
2015 Q2	$992K	Buy	40,486 +38,448	+1,887%	+$792K	﹤0.01%	2762
2015 Q1	$37K	Buy	2,038 +50	+3%	+$1.01K	﹤0.01%	3354
2014 Q4	$37K	Sell	1,988 -105	-5%	-$1.25K	﹤0.01%	3376
2014 Q3	$20K	Buy	2,093 +1,064	+103%	+$10.6K	﹤0.01%	3424
2014 Q2	$9K	Buy	+1,029	New	+$9.39K	﹤0.01%	3705

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Investment Management's LJPC Position: Q4 2016 in Review

BlackRock Investment Management increased its La Jolla Pharmaceutical Company (LJPC) stake by 0.58% in Q4 2016, buying an estimated $6.17K and bringing the position to 56,235 shares worth $986K. The position accounts for ﹤0.01% of the portfolio, ranked #2707.

BlackRock Investment Management first reported a position in LJPC in Q2 2014 and has held it in 11 quarters since. The position peaked at $1.33M in Q3 2016. 62 funds tracked by Wall St. Rank hold LJPC as of Q4 2016.

BlackRock Investment Management held 56,235 shares of La Jolla Pharmaceutical Company worth $986K as of Q4 2016.
BlackRock Investment Management bought 322 La Jolla Pharmaceutical Company shares in Q4 2016, an estimated $6.17K.
La Jolla Pharmaceutical Company made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2707 holding.
BlackRock Investment Management first reported a position in La Jolla Pharmaceutical Company in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's La Jolla Pharmaceutical Company position peaked at $1.33M in Q3 2016.
62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.